#Ocrelizumab – How Ocrelizumab Works

0
(0)

news-33

Ocrelizumab, an anti-CD20 monoclonal antibody, targets mature B-cells. Almost 95% of the B-cell population has these antigenic epitopes after maturation and does not shed them, which is what makes it a potent marker for therapeutic purposes (cancer being a very common area of interest in this regard).

Read more about Ocrelizumab here: http://bit.ly/1JUBLqj

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

7 comments

  1. LYNNE HEAL says:

    This drug is not good at all please do all the research on as many have died after taking this one . PLEASE BE CAREFUL

  2. LYNNE HEAL says:

    Also note that MS societys are also promoted this drug along with many more too. Billions has been made from MS patients who have all been exploted for financial gains

  3. LYNNE HEAL says:

    EXPLOITED excuse my spellings . Lots of are all being exploited with MS because they all know many are bedridden and unable to use a computer thats how sick it all is

  4. Jill says:

    I have been taking ocrelizumab for 5 years with no side effects and my ms stopped progressing after 6 months of treatment. The results have been amazing for me.

Leave a Comment

Your email address will not be published. Required fields are marked *